Nonstructural Protein 4B Market Is Likely to Experience a Tremendous Growth by 2029
Nonstructural Protein 4B Market is anticipated to grow at a significant CAGR during the forecast period. Nonstructural protein 4B (NS4B) induces the specific membrane alteration and is elected as a membranous web (MW). It is an integral membrane protein that is predicted to comprise four transmembrane segments in its central part. The major factor contributing to the growth of the market is the increasing prevalence of hepatitis across the globe.
According to World Health
Organization (WHO), in 2021, an estimated 58 million people have chronic
hepatitis C virus infection globally. Additionally, an estimated 1.5 million
new infections occur every year. Furthermore, approximately 290,000
people died from hepatitis C mostly due to cirrhosis and hepatocellular carcinoma
(primary liver cancer) in 2019. Moreover, over 95% of persons with hepatitis C
infection are cured by antiviral medicines. Hence, the rising prevalence of the
disease is driving the demand for nonstructural protein 4Bs for the treatment
which in turn is driving the growth of the market.
Some major players in the market
include Gilead Sciences, Inc., Johnson and Johnson Services, Inc., and AbbVie
Inc., among others. The market players are contributing significantly to the
growth of the market by the adoption of various strategies including mergers
& acquisitions, geographical expansion, partnerships and collaborations,
and new product launches, to stay competitive in the market. For instance, in
September 2019, AbbVie announced that it has received FDA approval for Mavyret
(Glecaprevir/Pibrentasvir). It is used to shorten the treatment duration to
eight weeks for the treatment of patients with chronic hepatitis c and
compensated cirrhosis across all genotypes
To Request a Sample of our Report on Nonstructural
Protein 4B Market: https://www.omrglobal.com/request-sample/nonstructural-protein-4b-market
Market Coverage
• The market number available for – 2021-2029
• Base year- 2021
• Forecast period- 2023-2029
Segment Covered-
·
By Type
·
By Application
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape- Gilead
Sciences, Inc., Johnson and Johnson Services, Inc., and AbbVie Inc., among
others.
Nonstructural Protein 4B Market Report by Segment
By Type
• INO-8000
• GSK-8853
• PTC-725
• RL-15A
• Others
By Application
• Hospital
• Clinics
• Others
A
full Report of Nonstructural Protein 4B Market is Available @ https://www.omrglobal.com/industry-reports/nonstructural-protein-4b-market
Nonstructural Protein 4B Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment